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In radiotherapy center, the waiting time represents one of the
most greater problems. The principal cause of this phenomenon
is represented by a smaller offer in comparison to the demand.
In fact, in these last years the application of radiotherapy is
increased both for the most greater incidence of new cases of can-
cer and for a greater extension in the radiotherapy indications. The
delay in the beginning of the radiant treatment has on the patient
negative effects is direct (what the tumoral growth, the worsening
of the symptoms, the psychological effects) both indirect effects
like trips of the hope and pressure on the radiation oncologist, that
can jeopardize the quality of the same radiant treatment. Numer-
ous evidences have shown that the delay in to begin can influence
the obtainable results with the radiotherapy, allowing the prolifer-
ation of clonogenic cells inside the target and consequently a dim-
inution of the local control. Besides the delay in the beginning of
the radiotherapy can influence negatively the process of onset of
the metastasis. None of the numerous present evidences in litera-
ture on the influence of the delay of the radiotherapy and that they
suggest the role of the delay of the radiotherapy in the increase of
the risk of local relapse, it reaches the level of ‘evidence-based
medicine’. In fact anybody study show a clear relationship among
cause and effect, besides none of these studies has been drawn to
the purpose to verify if this relationship exists. It is reasonable
however to think that, through the improvements reached in the
knowledge of the tumoral progression in the patients waiting for
radiotherapy, especially as it regards the patients affections from
the head and the neck cancer, the delay of the I begin some radio-
therapy is responsible of many local failures. Although the effects
of the delay of the radiotherapy is not the same for all the tumors,
the negative effects tied up to it, can frustrate the benefits effects
reached by the technological advancements of the radiotherapy.
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Until now, the majority of the cancer therapy have not been
specific: not based on the tumour biology and associated to a
meaningful toxicity. The classical radiobiology has furnished
valid elements on the cellular kinetics, has furnished valid ele-
ments on the cellular kinetics, on the processes of reparation
and damage of the DNA and on the biological basis of administra-
tion of the dose, putting the bases for the new radiobiology,
regarding the interactions of radiation ionizing and molecular-
targeted agents. In the last years the therapeutic approach to
the tumour is changed: the target of the cancer therapies is not
more directly the neoplastic cells but is directed against targets
necessary for tumour cell growth and viability with little toxicity
to normal cells compared to conventional cytotoxic agents (Fig. 1).
Moreover, the modern radiobiology it is turned toward the
molecular biology, not more the DNA as target but not DNA tar-
gets: specific growth factor or signal transduction inhibitors, as
CDK, PKC, EGFR, VEGF, FT, MAPK. The non-DNA targets they
result effective in to determine the cellular death or to make
the most sensitive cells to the radiations. In 2006, Bunn1 reported
that ‘Targeted therapy and radiation may work together in two
Fig. 1. The combination of targeted therapy and radiother-
apy to treat cancer (Giaccia A. ASTRO 2007).
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